PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Dalteparin sodium - Pre-operative / bridging therapy
PAD Profile : Dalteparin sodium - Pre-operative / bridging therapy
Keywords :
Low Molecular Weight Heparins, LMWH
Brand Names Include :
Fragmin
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
- VTE prevention post hip/knee replacement
- VTE prophylaxis
- VTE treatment in patients unable to take oral anticoagulants
- VTE treatment in pregnancy
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
28 April 2010
Not Set
The committee were informed that pre-operative LMWH is included within the PbR tariff and should therefore be prescribed/provided by the acute trusts. It should be noted that private patients should not receive care that is different to that of NHS patients and on that principle, the pre-operative LMWH should form part of that patients' private care
Associated BNF Codes
02. Cardiovascular System
02.08.01. Parenteral anticoagulants